New implantable ultrasound tackles bench-to-bedside failures

After 17 years developing an implantable ultrasound platform for blood-brain barrier modulation, a researcher argues that medical innovations fail in clinical trials because core translational issues weren't addressed early enough. The piece suggests a rethink of how we move promising lab tech to actual patients, especially for complex systems like the brain.